Home > Balance Sheet > BLISS GVS PHARMA

BLISS GVS PHARMA
Contingent Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹59 Cr₹57 Cr₹12 Cr₹23 Cr₹30 Cr

What is the latest Contingent Liabilities ratio of BLISS GVS PHARMA ?

The latest Contingent Liabilities ratio of BLISS GVS PHARMA is ₹59 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹59 Cr
Mar2024₹57 Cr
Mar2023₹12 Cr
Mar2022₹23 Cr
Mar2021₹30 Cr

How is Contingent Liabilities of BLISS GVS PHARMA Trending?

Years Contingent Liabilities % Change
Mar2025 ₹59 Cr
3.45
Mar2024 ₹57 Cr
390.81
Mar2023 ₹12 Cr
-48.95
Mar2022 ₹23 Cr
-25.09
Mar2021 ₹30 Cr -

Compare Contingent Liabilities of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹1,808.0 Cr 9.8% 12.6% 1.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,068.0 Cr -0.2% 7.1% 1.1% Stock Analytics
DIVIS LABORATORIES ₹171,847.0 Cr 0.8% -6% 4.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,985.0 Cr 1.2% 6.4% 13.1% Stock Analytics
CIPLA ₹122,826.0 Cr -0.2% 1.4% -0.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,418.0 Cr 1.2% 5.8% 4.2% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

9.8%

12.6%

1.9%

SENSEX

0%

2.7%

6.8%


You may also like the below Video Courses